XENE logo

Xenon Pharmaceuticals Inc


XENE: Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.


Show XENE Financials

Consumer Interest
SEC Filings

Recent trades of XENE by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by XENE's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of XENE in WallStreetBets Daily Discussion


Recent insights relating to XENE

CNBC Recommendations

Recent picks made for XENE stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in XENE

Corporate Flights

Flights by private jets registered to XENE